Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
A2Care is a Japanese healthcare company specializing in infection control and hygiene solutions powered by the proprietary MA-T (Matching Transformation System) technology. Developed in collaboration with Osaka University, MA-T is a chemical platform that enables the controlled release of chlorine dioxide, providing potent antimicrobial and antiviral activity while maintaining high safety standards for human contact. The company's products are widely deployed across the healthcare, transportation, and consumer sectors, notably serving as the standard disinfectant for All Nippon Airways (ANA) and numerous Japanese hospitals. A2Care is actively expanding the medical applications of its platform, with ongoing research into oral care products designed to prevent aspiration pneumonia and other infectious complications in clinical settings.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on a2care.